Cardiol Therapeutics, Inc. (CRDL)
1.12
-0.03
(-2.61%)
USD |
NASDAQ |
Oct 23, 16:00
1.17
+0.05
(+4.46%)
After-Hours: 06:11
Cardiol Therapeutics EPS Diluted (Quarterly) : -0.0382 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0382 |
| March 31, 2026 | -0.0724 |
| December 31, 2025 | -0.0516 |
| September 30, 2025 | -0.0854 |
| June 30, 2025 | -0.073 |
| March 31, 2025 | -0.0699 |
| December 31, 2024 | -0.0715 |
| September 30, 2024 | -0.1336 |
| June 30, 2024 | -0.0701 |
| March 31, 2024 | -0.1012 |
| December 31, 2023 | -0.0858 |
| September 30, 2023 | -0.0686 |
| June 30, 2023 | -0.0868 |
| March 31, 2023 | -0.0818 |
| December 31, 2022 | -0.0864 |
| September 30, 2022 | -0.0979 |
| June 30, 2022 | -0.0821 |
| March 31, 2022 | -0.1142 |
| December 31, 2021 | -0.0873 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.1822 |
| June 30, 2021 | -0.1334 |
| March 31, 2021 | -0.2033 |
| December 31, 2020 | -0.2258 |
| September 30, 2020 | -0.1007 |
| June 30, 2020 | -0.0939 |
| March 31, 2020 | -0.0847 |
| December 31, 2019 | -0.0895 |
| September 30, 2019 | -0.1022 |
| June 30, 2019 | -0.1053 |
| March 31, 2019 | -0.1023 |
| December 31, 2018 | -0.3772 |
| September 30, 2018 | -0.1622 |
| June 30, 2018 | -0.0454 |
| March 31, 2018 | -0.0188 |
| December 31, 2017 | -0.0206 |
| September 30, 2017 | -0.0178 |
| June 30, 2017 | -0.0142 |
| March 31, 2017 | -0.0031 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -1.434 |
| NervGen Pharma Corp. | -0.0925 |
| Milestone Pharmaceuticals, Inc. | -0.2063 |
| Appili Therapeutics, Inc. | -0.0093 |
| Clearmind Medicine, Inc. | -4.588 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.393M |
| Total Expenses (Quarterly) | 4.393M |
| Enterprise Value | 111.48M |
| Earnings Yield | -22.11% |
| Normalized Earnings Yield | -22.35 |